TAVALISSE 100 mg/1
FOSTAMATINIB · TABLET · Rigel Pharmaceuticals, Inc.
No Recall History
Plain English
TAVALISSE is a tablet containing fostamatinib at 100 mg/1, taken oral. Manufactured by Rigel Pharmaceuticals, Inc..
Key Facts
- Brand Name
- TAVALISSE
- Generic Name
- FOSTAMATINIB
- NDC Code (Product)
71332-001- Manufacturer
- Rigel Pharmaceuticals, Inc.
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA209299
- Marketing Start
- 05/09/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is TAVALISSE used for?
TAVALISSE contains FOSTAMATINIB. It is a tablet taken oral. Consult your doctor for specific uses.
Is TAVALISSE a controlled substance?
TAVALISSE is not classified as a controlled substance by the DEA.
What is the generic name for TAVALISSE?
The generic name for TAVALISSE is FOSTAMATINIB. There are no other listed brand versions of FOSTAMATINIB.
What is the NDC code for TAVALISSE 100 mg/1?
The NDC (National Drug Code) for TAVALISSE 100 mg/1 is 71332-001, listed by Rigel Pharmaceuticals, Inc..
Other TAVALISSE Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)